A Randomized, Single-Blind, Crossover Study in Healthy Volunteers to Demonstrate the Bioequivalence of AVONEX® (Interferon Beta-1a) Solutions for Injection Produced by a Serum-Containing Manufacturing Process and by a Serum-Free Manufacturing Process

CompletedPhase 1MS (type not specified)NCT00913250

What it found

No results found

We found no results in the registry or in papers.

This trial finished 23 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

What it measured

Main measures

  • To demonstrate the bioequivalence of a serum-free Avonex and a serum-containing AVONEX® when given intramuscularly (IM) to healthy volunteers.

    Study duration is 72 days

Who could take part

MS (type not specified) · 18 to 45

Show the full criteria

Inclusion criteria

* Healthy Volunteers

Exclusion criteria

* History of severe allergic or anaphylactic reactions * History of hypersensitivity to acetaminophen (paracetamol), ibuprofen, or codeine. * Known allergy to dry natural rubber * History of seizure disorder or unexplained blackouts * History of any clinically significant (as determined by the Investigator) cardiac, endocrinologic, hematologic, hepatic, immunologic, metabolic, urologic, pulmonary, neurologic, dermatologic, psychiatric, renal, and/or other major disease Other inclusion and exclusion criteria apply as per protocol

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Demonstrate the bioequivalence of a serum-free solution to a serum containing solution of Avonex.

Loading reviews and guidelines…

Related trials

History

    1. Started

      Aug 2003

    2. Finished

      Oct 2003

    Assembled by software from public sources.